Journal article

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer

L Bazzola, C Foroni, D Andreis, V Zanoni, MR Cappelletti, G Allevi, S Aguggini, C Strina, M Milani, S Venturini, F Ferrozzi, R Giardini, R Bertoni, H Turley, K Gatter, PG Petronini, SB Fox, AL Harris, M Martinotti, A Berruti Show all

British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2015